Cargando…
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
BACKGROUND: Gabapentin and pregabalin are commonly prescribed medications to treat pain in patients with diabetic neuropathy. Gabapentin and pregabalin can cause fluid retention, which is hypothesized to be associated with cardiovascular diseases. However, whether long-term use of gabapentin and pre...
Autores principales: | Pan, Yiheng, Davis, Pamela B., Kaebler, David C., Blankfield, Robert P., Xu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438165/ https://www.ncbi.nlm.nih.gov/pubmed/36050764 http://dx.doi.org/10.1186/s12933-022-01610-9 |
Ejemplares similares
-
Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
por: Devi, Padmini, et al.
Publicado: (2012) -
Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012) -
Mirogabalin: could it be the next generation gabapentin or pregabalin?
por: Kim, Jae-Yeon, et al.
Publicado: (2021) -
Rational dosing of gabapentin and pregabalin in chronic kidney disease
por: Raouf, Mena, et al.
Publicado: (2017) -
Do gabapentin or pregabalin directly modulate the µ receptor?
por: Manandhar, Preeti, et al.
Publicado: (2021)